Simplex Trading’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.27K | Sell |
374
-771
| -67% | -$2.62K | ﹤0.01% | 8517 |
|
|
2025
Q4 | $3.26K | Buy |
+1,145
| New | +$2.95K | ﹤0.01% | 7644 |
|
|
2025
Q2 | – | Sell |
-7,244
| Closed | -$16K | – | 9452 |
|
|
2025
Q1 | $15K | Buy |
7,244
+3,387
| +88% | +$7.82K | ﹤0.01% | 6804 |
|
|
2024
Q4 | $9K | Buy |
+3,857
| New | +$9.17K | ﹤0.01% | 7277 |
|
|
2024
Q3 | – | Sell |
-75
| Closed | -$183 | – | 9272 |
|
|
2024
Q2 | $0 | Buy |
+75
| New | +$178 | ﹤0.01% | 9541 |
|
|
2023
Q4 | – | Sell |
-2,496
| Closed | -$5.33K | – | 9542 |
|
|
2023
Q3 | $6K | Sell |
2,496
-3,600
| -59% | -$11.3K | ﹤0.01% | 7554 |
|
|
2023
Q2 | $21K | Buy |
+6,096
| New | +$19.5K | ﹤0.01% | 6733 |
|
|
2023
Q1 | – | Sell |
-38,427
| Closed | -$122K | – | 9830 |
|
|
2022
Q4 | $462K | Sell |
38,427
-4,791
| -11% | -$37.2K | ﹤0.01% | 3230 |
|
|
2022
Q3 | $280K | Buy |
43,218
+22,855
| +112% | +$185K | ﹤0.01% | 4172 |
|
|
2022
Q2 | $93K | Buy |
+20,363
| New | +$109K | ﹤0.01% | 5657 |
|
|
2022
Q1 | – | Sell |
-6,930
| Closed | -$71K | – | 11125 |
|
|
2021
Q4 | $98K | Buy |
+6,930
| New | +$145K | ﹤0.01% | 6281 |
|
|
2020
Q4 | – | Sell |
-24,124
| Closed | -$78.5K | – | 8871 |
|
|
2020
Q3 | $62K | Buy |
+24,124
| New | +$84K | ﹤0.01% | 5403 |
|
|
2020
Q1 | – | Sell |
-6,104
| Closed | -$26.7K | – | 8073 |
|
|
2019
Q4 | $31K | Buy |
+6,104
| New | +$22.9K | ﹤0.01% | 5632 |
|
|
2019
Q3 | – | Sell |
-1,775
| Closed | -$5.91K | – | 7701 |
|
|
2019
Q2 | $6K | Buy |
+1,775
| New | +$6.26K | ﹤0.01% | 6369 |
|
|
2019
Q1 | – | Sell |
-1,035
| Closed | -$3K | – | 7652 |
|
|
2018
Q4 | $3K | Buy |
1,035
+488
| +89% | +$2.02K | ﹤0.01% | 6443 |
|
|
2018
Q3 | $2K | Buy |
+547
| New | +$2.84K | ﹤0.01% | 7093 |
|
|
2016
Q4 | – | Sell |
-2,673
| Closed | -$19K | – | 6332 |
|
|
2016
Q3 | $19K | Sell |
2,673
-1,500
| -36% | -$11.7K | ﹤0.01% | 3029 |
|
|
2016
Q2 | $34K | Buy |
4,173
+3,421
| +455% | +$29.1K | ﹤0.01% | 2414 |
|
|
2016
Q1 | $5K | Sell |
752
-2,425
| -76% | -$16.2K | ﹤0.01% | 4102 |
|
|
2015
Q4 | $27K | Buy |
+3,177
| New | +$24.1K | ﹤0.01% | 2446 |
|
|
2015
Q1 | – | Sell |
-175
| Closed | -$845 | – | 5419 |
|
|
2014
Q4 | $1K | Buy |
+175
| New | +$1.15K | ﹤0.01% | 4212 |
|
Other funds holding ORMP
BCM
AF
GIA
M
BFM
RG
Simplex Trading's ORMP Position: Q1 2026 in Review
Simplex Trading reduced its Oramed Pharmaceuticals (ORMP) stake by 67% in Q1 2026, selling an estimated $2.62K and leaving 374 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #8517.
Simplex Trading first reported a position in ORMP in Q4 2014 and has held it in 21 quarters since. The position peaked at $462K in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.
- Simplex Trading held 374 shares of Oramed Pharmaceuticals worth $1.27K as of Q1 2026.
- Simplex Trading sold 771 Oramed Pharmaceuticals shares in Q1 2026, an estimated $2.62K.
- Oramed Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8517 holding.
- Simplex Trading first reported a position in Oramed Pharmaceuticals in Q4 2014 and has held it in 21 quarters since.
- Simplex Trading's Oramed Pharmaceuticals position peaked at $462K in Q4 2022.
- 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.